The Infection Control Today® COVID-19 page brings readers the latest information and clinical updates on the coronavirus disease 2019 pandemic, from case counts and hospitalization rates to data on effective treatments for severe disease and the circulating viral variants.
May 2nd 2024
Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Ambulatory Surgical Centers: Preparing for the Next Day or the Next Pandemic
April 3rd 2023Ambulatory surgical centers (ASC) were a main topic at the AORN 2023 Conference, and Erica Smith, MBA, PhD candidate, tells ICT about her presentation on the importance of infection control and prevention in the ASC.
AORN President Discusses Past and Present Goals and the 2023 Conference
April 2nd 2023Vangie Dennis, MSN, RN, CNOR, CMLSO, president of the Association of PeriOperative Nurses (AORN), discusses the goals she and the Board of Directors reached during her tenure, the future of AORN, and the annual conference in San Antonio, Texas.
COVID-19: Study Suggests Long-term Damage to Immune System
March 21st 2023NIH News Release: "...findings suggest that SARS-CoV-2 infection damages the CD8+ T cell response, an effect akin to that observed in earlier studies showing long-term damage to the immune system after infection with viruses such as hepatitis C or HIV."
Is the Rise in RSV Infections Associated With Immune Debt or SARS-CoV-2 Immune Dysfunction?
February 23rd 2023Post-COVID-19 immune dysfunction is supported by epidemiological, clinical, and laboratory evidence. Attributing, with little to no evidence, that masking and lack of exposure is the primary driver of increases in bacterial and viral infections discourages critical interventions needed to stop the spread of disease.